These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 12911549

  • 1. Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia.
    Shiizaki K, Hatamura I, Negi S, Narukawa N, Mizobuchi M, Sakaguchi T, Ooshima A, Akizawa T.
    Kidney Int; 2003 Sep; 64(3):992-1003. PubMed ID: 12911549
    [Abstract] [Full Text] [Related]

  • 2. Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.
    Shiizaki K, Negi S, Hatamura I, Sakaguchi T, Saji F, Kunimoto K, Mizobuchi M, Imazeki I, Ooshima A, Akizawa T.
    J Am Soc Nephrol; 2005 Jan; 16(1):97-108. PubMed ID: 15574509
    [Abstract] [Full Text] [Related]

  • 3. Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats.
    Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Imazeki I, Kusano E, Shigematsu T, Akizawa T.
    Nephrol Dial Transplant; 2008 May; 23(5):1529-36. PubMed ID: 18156462
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
    Tanaka M, Itoh K, Matsushita K, Matsushita K, Fukagawa M.
    Nephron Clin Pract; 2006 May; 102(1):c1-7. PubMed ID: 16166800
    [Abstract] [Full Text] [Related]

  • 5. Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.
    Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Kunimoto K, Okamoto M, Imazeki I, Muragaki Y, Akizawa T.
    Kidney Int; 2006 Aug; 70(3):486-95. PubMed ID: 16788697
    [Abstract] [Full Text] [Related]

  • 6. Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection.
    Shiizaki K, Hatamura I, Nakazawa E, Ogura M, Masuda T, Akizawa T, Kusano E.
    Med Mol Morphol; 2008 Jun; 41(2):76-82. PubMed ID: 18592161
    [Abstract] [Full Text] [Related]

  • 7. Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells.
    Shiizaki K, Negi S, Hatamura I, Tatsuta K, Shibata M, Shimada S, Sakaguchi T, Akizawa T.
    Kidney Int Suppl; 2006 Jul; (102):S12-5. PubMed ID: 16810304
    [Abstract] [Full Text] [Related]

  • 8. Binding of highly concentrated maxacalcitol to the nuclear vitamin D receptors of parathyroid cells.
    Shiizaki K, Hayakawa N, Imazeki I, Hatamura I, Okada T, Negi S, Sakaguchi T, Shigematsu T, Akizawa T.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1078-86. PubMed ID: 17234669
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of weekly percutaneous maxacalcitol injection therapy in patients with secondary hyperparathyroidism.
    Saito A, Matsumoto Y, Oyama Y, Asaka M, Yokoyama H.
    Ther Apher Dial; 2010 Feb; 14(1):98-103. PubMed ID: 20438525
    [Abstract] [Full Text] [Related]

  • 10. Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.
    Tominaga Y, Matsuoka S, Sato T, Uno N, Goto N, Katayama A, Haba T, Kazuharu Uchida (Yagoto PTx Forum).
    Ther Apher Dial; 2007 Aug; 11(4):266-73. PubMed ID: 17661832
    [Abstract] [Full Text] [Related]

  • 11. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
    Mao J, Wang M, Ni L, Gong W, Jiang X, Zhang Q, Zhang M, Wen D, Chen J.
    Endocrinology; 2021 Jul 01; 162(7):. PubMed ID: 33912936
    [Abstract] [Full Text] [Related]

  • 12. Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients.
    Shiizaki K, Negi S, Mizobuchi M, Hatamura I, Narukawa N, Sakaguchi T, Kitabata Y, Sumikado S, Akizawa T.
    Nephrol Dial Transplant; 2003 Jun 01; 18 Suppl 3():iii42-6. PubMed ID: 12771299
    [Abstract] [Full Text] [Related]

  • 13. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
    Lomonte C, Martino R, Selvaggiolo M, Bona RM, Cazzato F, Milano R, Chiarulli G, Basile C.
    J Nephrol; 2003 Jun 01; 16(5):716-20. PubMed ID: 14733419
    [Abstract] [Full Text] [Related]

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 15. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A, Canalejo R, Rodriguez ME, Martinez-Moreno JM, Felsenfeld AJ, Rodríguez M, Almaden Y.
    Nephrol Dial Transplant; 2010 Apr 01; 25(4):1087-97. PubMed ID: 19934096
    [Abstract] [Full Text] [Related]

  • 16. Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia.
    Shiizaki K, Fukagawa M, Yuan Q, Hatamura I, Nii-Kono T, Saji F, Shigematsu T, Akizawa T.
    Am J Nephrol; 2008 Apr 01; 28(1):59-66. PubMed ID: 17901691
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism.
    Nakanishi S, Yano S, Nomura R, Tsukamoto T, Shimizu Y, Shin J, Fukagawa M.
    Nephrol Dial Transplant; 2003 Jun 01; 18 Suppl 3():iii47-9. PubMed ID: 12771300
    [Abstract] [Full Text] [Related]

  • 18. Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients.
    Yamamoto H, Katoh N, Takeyama H, Ikeda M, Yokoyama K, Shigematsu T, Kawaguchi Y, Hosoya T.
    Nephrol Dial Transplant; 2003 Jun 01; 18 Suppl 3():iii50-2. PubMed ID: 12771301
    [Abstract] [Full Text] [Related]

  • 19. The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.
    Arcidiacono MV, Yang J, Fernandez E, Dusso A.
    Nephrol Dial Transplant; 2015 Mar 01; 30(3):423-33. PubMed ID: 25294851
    [Abstract] [Full Text] [Related]

  • 20. Apoptosis in parathyroid hyperplasia of patients with primary or secondary uremic hyperparathyroidism.
    Zhang P, Duchambon P, Gogusev J, Nabarra B, Sarfati E, Bourdeau A, Drüeke TB.
    Kidney Int; 2000 Feb 01; 57(2):437-45. PubMed ID: 10652020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.